Geoffrey Allen

Q: What Schools Are Affiliated With Geoffrey Allen

Geoffrey Allen is affiliated with the following schools: Victoria University of Manchester, University of Kentucky, Imperial College London, University of Leeds, University of Oxford, Wayne State University, University of Manchester, Macquarie University

Geoffrey Allen 's AcademicInfluence.com Rankings

Geoffrey Allen

Chemistry

#3372

World Rank

#4387

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Geoffrey Allen 's Degrees

Bachelors Chemistry University of Oxford
PhD Chemistry University of Oxford

Why Is Geoffrey Allen Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sir Geoffrey Allen was a British chemist who also served as a Vice-President of the Royal Society. He was primarily known for his work on the physics and chemistry of polymers. Allen was especially well known for his work on the thermodynamics of rubber elasticity. He inspired a generation of physical chemists as a result of his research interests, and he had a passion for fostering links between academia and industry.

(See a Problem?)

Geoffrey Allen 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Analysis of Equid Herpesvirus 1 Strain Variation Reveals a Point Mutation of the DNA Polymerase Strongly Associated with Neuropathogenic versus Nonneuropathogenic Disease Outbreaks (2006) (261)
Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. (1986) (261)
Outbreak of neurologic disease caused by equine herpesvirus-1 at a university equestrian center. (2007) (183)
Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1 (1987) (115)
Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. (2008) (109)
Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1 (1995) (103)
Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. (2010) (100)
Molecular epizootiologic studies of equine herpesvirus-1 infections by restriction endonuclease fingerprinting of viral DNA. (1983) (97)
Antiviral Activity of Arabinosylthymine in Herpesviral Replication: Mechanism of Action In Vivo and In Vitro (1977) (91)
Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky. (2008) (90)
Characterization of an equine herpesvirus type 1 gene encoding a glycoprotein (gp13) with homology to herpes simplex virus glycoprotein C (1988) (89)
In Vitro Activities of Quinupristin-Dalfopristin and Cefepime, Alone and in Combination with Various Antimicrobials, against Multidrug-Resistant Staphylococci and Enterococci in an In Vitro Pharmacodynamic Model (2002) (83)
The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens. (2010) (82)
The increased prevalence of neuropathogenic strains of EHV-1 in equine abortions. (2010) (78)
Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals (1989) (76)
Equine herpesvirus type 1 unique short fragment encodes glycoproteins with homology to herpes simplex virus type 1 gD, gI and gE. (1990) (72)
Rapid subtyping of equine herpesvirus 1 with monoclonal antibodies (1985) (66)
Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies. (1999) (65)
Activities of Mutant Prevention Concentration-Targeted Moxifloxacin and Levofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacodynamic Model (2003) (63)
Development of a Real-Time Polymerase Chain Reaction Assay for Rapid Diagnosis of Neuropathogenic Strains of Equine Herpesvirus-1 (2007) (59)
Antemortem detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses. (2006) (59)
Serologic and molecular comparisons of several equine herpesvirus type 1 strains. (1981) (57)
Herpesviral Diseases of the Horse (1989) (56)
Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies. (1991) (53)
In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model. (2004) (52)
Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity (1990) (52)
Identification of the envelope surface glycoproteins of equine herpesvirus type 1. (1982) (51)
A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. (1989) (49)
Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes. (2003) (48)
Alterations in the equine herpesvirus 1 genome after in vitro and in vivo virus passage (1983) (48)
Antigenic and protein sequence homology between VP13/14, a herpes simplex virus type 1 tegument protein, and gp10, a glycoprotein of equine herpesvirus 1 and 4 (1991) (46)
Activities of LY333328 and Vancomycin Administered Alone or in Combination with Gentamicin against Three Strains of Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model (2000) (45)
A new field strain of equine abortion virus (equine herpesvirus-1) among Kentucky horses. (1985) (42)
Assessment of the base sequence homology between the two subtypes of equine herpesvirus 1 (1982) (40)
Epidemic disease caused by Equine herpesvirus-1: recommendations for prevention and control (2010) (39)
Multiple abortions associated with caprine herpesvirus infection in a goat herd. (1997) (34)
Purification and characterization of equine herpesvirus-induced DNA polymerase (1977) (34)
Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. (2006) (34)
Synthesis and processing of equine herpesvirus type 1 glycoprotein 14. (1989) (32)
Equine herpesvirus type 1 abortion in an onager and suspected herpesvirus myelitis in a zebra. (1985) (30)
Equine viral rhinopneumonitis. (1986) (30)
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis (2008) (30)
Transmission of EHV-1 by Horses with EHV-1 Myeloencephalopathy: Implications for Biosecurity and Review (2006) (29)
Efficacy of the early administration of valacyclovir hydrochloride for the treatment of neuropathogenic equine herpesvirus type-1 infection in horses. (2017) (28)
In vitro and in vivo Studies of Equine ‘Coital’ Exanthema (1974) (26)
Genetic relatedness and pathogenicity of equine herpesvirus 1 isolated from onager, zebra and gazelle (2007) (26)
Abortion and perinatal foal mortality associated with equine herpesvirus type 1 in a herd of Grevy's zebra. (1986) (25)
Genetic relatedness of equine herpesvirus types 1 and 3 (1977) (24)
Encephalitis associated with a variant of equine herpesvirus 1 in a Thomson's gazelle ( Gazella thomsonii) (1996) (24)
The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge. (1996) (23)
Molecular dissection of two major equine herpesvirus-1 glycoprotein antigens (GB and GC) that elicit humoral immune responses in the horse (1992) (23)
Comparative in vitro activities of topical wound care products against community-associated methicillin-resistant Staphylococcus aureus. (2008) (20)
Polymorphism of open reading frame 71 of equine herpesvirus-4 (EHV-4) and EHV-1. (2002) (19)
The highly O-glycosylated glycoprotein gp2 of equine herpesvirus 1 is encoded by gene 71 (1996) (18)
Characterization of equid herpesvirus 1 (EHV-1) related viruses from captive Grevy's zebra and blackbuck. (2006) (17)
Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1 (2005) (17)
Replication of equine herpesvirus type 1 and type 3: resistance to hydroxyurea and thymidine. (1978) (17)
Induction of deoxythymidine kinase activity in several mammalian cell lines after infection with six different strains of equine herpesvirus type 1 (EHV-1). (1978) (16)
Detection of Equid herpesvirus 9 DNA in the trigeminal ganglia of a Burchell's zebra from the Serengeti ecosystem. (2008) (16)
Thymine salvage, mitochondria, and the evolution of the herpesviruses. (1983) (15)
Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA). (2010) (15)
Replication of equine herpesvirus type 3: kinetics of infectious particle formation and virus nucleic acid synthesis. (1977) (15)
In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium. (2009) (15)
The DNA sequence of the equine herpesvirus 4 gene encoding glycoprotein gp17/18, the homologue of herpes simplex virus glycoprotein gD. (1993) (14)
Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract. (2006) (12)
Proteins of equine herpesvirus type 3. I. Polypeptides of the purified virion. (1979) (12)
Risk factors associated with linezolid-nonsusceptible enterococcal infections. (2012) (12)
Purification and characterization of deoxythymidine kinase (dTK) induced in dTK- 3T3 mouse cells by equine herpesvirus type 1 (EHV-1). (1979) (11)
Biochemical transformation of deoxythymidine kinase-deficient mouse cells with UV-irradiated equine herpesvirus type 1 (1978) (11)
Cell-free synthesis of equine herpesvirus type 3 nucleocapsid polypeptides. (1976) (11)
Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I. (1982) (10)
Impact of Antimicrobial Control Programs on Patient Outcomes (2003) (8)
Biochemical characterization of equine herpesvirus type 3-induced deoxythymidine kinase purified from lytically infected horse embryo dermal fibroblasts (1980) (8)
Arabinosylthymine, a selective inhibitor of herpesvirus replication: current status of in vivo studies. (1979) (7)
Antiviral Activity ofArabinosylthymine inHerpesviral Replication: Mechanism ofAction InVivoandInVitro (1977) (6)
Arabinosylthymine: in vivo effectiveness in a systemic herpesvirus infection. (1978) (6)
In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin (2017) (5)
Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae. (2009) (5)
Oncogenic transformation of non-permissive murine cells by viable equine herpesvirus type 1 (EHV-1) and EHV-1 DNA. (1978) (5)
Biological properties of equine herpesvirus type 1 DNA: transfectivity and transforming capacity (1978) (4)
Deoxythymidine kinase metabolism in equine herpesvirus type 3 infected horse embryo dermal fibroblasts. (1980) (4)
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae. (2021) (3)
Purification and biochemical characterization of deoxythymidine kinase of deoxythymidine kinase-deficient mouse 3T3 cells biochemically transformed by equine herpesvirus type 1 (1979) (3)
The Equine Virology Research Foundation--a view from abroad. (1994) (3)
Molecular pathogenesis of equine coital exanthema: restriction endonuclease digestions of EHV-3 DNA and indications of a unique XbaI cleavage site. (1985) (3)
Studies of an established equine cell line derived from a transitional cell carcinoma. (1974) (3)
Risk Factors Associated with Linezolid Non-susceptible Enterococcal Infections (2013) (1)
The Increased Prevalence of Neuropathogenic Strains of EHV-1 in Equine 4 Abortions 5 6 7 (2019) (0)
Equine Disease Model for Herpesvirus Neurologic Disease and Uses Thereof (2017) (0)
Purification and characterization of equine herpesvirus-induced DNA. (1977) (0)
in horses infected with equine herpesvirus 1 . I-restricted cytotoxic T-lymphocyte responses Major histocompatibility complex class (1994) (0)
Biological Properties ofEquine Herpesvirus Type1DNA: Transfectivity andTransforming Capacity (1978) (0)
In Vitro Resistance Selection in Shigella ﬂexneri by Azithromycin, Ceftriaxone, Ciproﬂoxacin, Levoﬂoxacin, and Moxiﬂoxacin (2017) (0)
Construction and analysis of plasmid recombinants containing fragments of equine herpesvirus type 1 dna (1980) (0)
A Review of Levofloxacin for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis (2009) (0)
Alterations intheEquine Herpesvirus 1GenomeAfter In Vitro andInVivoVirus Passaget (1983) (0)
UseofXgtll andMonoclonal Antibodies ToMaptheGenesforthe SixMajorGlycoproteins ofEquine Herpesvirus It (1987) (0)

This paper list is powered by the following services:

Other Resources About Geoffrey Allen

en.wikipedia.org

What Schools Are Affiliated With Geoffrey Allen ?

Geoffrey Allen is affiliated with the following schools:

Geoffrey Allen 's Academic­Influence.com Rankings